Diagnostic Imaging Equipment Market by Product Type (Computed Tomography (CT) Scanners, Magnetic Resonance Imaging (MRI) Equipment, Nuclear Imaging Equipment), Portability (Fixed Imaging Equipment, Portable Imaging Equipment), Application, End-User - Glob
Description
The Diagnostic Imaging Equipment Market was valued at USD 44.70 billion in 2024 and is projected to grow to USD 47.27 billion in 2025, with a CAGR of 6.09%, reaching USD 71.77 billion by 2032.
A concise executive overview framing how technological convergence, care delivery shifts, and policy changes are redefining strategic priorities across diagnostic imaging
The diagnostic imaging equipment landscape is undergoing fundamental transformation driven by converging technological advances, regulatory evolution, and shifting care delivery models. As healthcare systems prioritize earlier diagnosis, minimally invasive interventions, and outpatient care expansion, imaging modalities are becoming central to clinical decision pathways and operational efficiency. Diagnostic imaging equipment manufacturers, hospital systems, and service providers must therefore recalibrate product road maps, deployment strategies, and value propositions to remain relevant in increasingly integrated care ecosystems.
This executive-level overview synthesizes key trends shaping the industry, highlights structural shifts in demand and supply, and identifies practical implications for manufacturers, distributors, and clinical stakeholders. It emphasizes the interplay between modality innovation and workflow optimization, and explores how emerging interoperability standards, AI-enabled interpretive tools, and modality convergence are reshaping procurement criteria and capital allocation choices. The goal is to equip decision-makers with a clear, concise narrative of market dynamics and strategic levers that can be acted upon to preserve competitive advantage and drive sustainable growth.
Key structural transformations including modality convergence, AI-enabled workflows, and care delivery migration that are reshaping procurement and deployment strategies
Several transformative shifts are reframing competitive dynamics and clinical utility across the diagnostic imaging ecosystem. Advancements in image acquisition hardware and software are accelerating cross-modality integration, enabling workflows where CT, MRI, ultrasound, nuclear imaging, and X-ray systems complement one another rather than operate in silos. This technical convergence is amplified by the proliferation of AI-enabled analytics that augment image interpretation, automate routine measurements, and prioritize case triage, thus changing expectations for diagnostic throughput and radiologist workflows.
Concurrently, care delivery is migrating toward outpatient, ambulatory, and point-of-care environments, which increases demand for portable and lower-footprint imaging solutions that preserve diagnostic fidelity. Value-based reimbursement models and bundled payments are shifting procurement emphasis toward total cost of ownership, clinical outcomes, and time-to-diagnosis metrics. Supply chain resilience and component sourcing strategies have also become strategic differentiators after recent disruptions, prompting manufacturers to diversify supply bases, localize critical manufacturing, and invest in service networks that reduce uptime risk. Collectively, these shifts are driving a re-evaluation of product design, go-to-market approaches, and partnership strategies across the value chain.
How tariff policy changes enacted in 2025 are reshaping manufacturing footprints, supply chain strategies, and procurement behaviors across the imaging equipment value chain
The cumulative effect of tariff adjustments and trade policy changes implemented in and around 2025 has introduced new layers of complexity into procurement, pricing, and supply chain planning for diagnostic imaging equipment. Tariff-induced cost pressures have compelled manufacturers to reassess component sourcing, production footprints, and pricing strategies for both established and emerging modalities. These adjustments have ripple effects across procurement cycles, capital planning horizons, and long-term service agreements for healthcare providers.
In response, manufacturers are increasingly pursuing near-shoring, diversified supplier ecosystems, and modular design principles that allow critical subassemblies to be sourced from multiple geographies without compromising regulatory compliance or product integrity. Service and spare parts logistics have been reprioritized to mitigate tariff-driven lead-time variability, with an emphasis on extended warranty structures and predictive maintenance contracts that stabilize total lifecycle costs for end users. At the system level, procurement teams are adopting more rigorous scenario planning, incorporating tariff sensitivity analyses into procurement committees, and prioritizing vendors who demonstrate transparent costing and resilient supply chains. Transitional policy shifts have therefore elevated supply chain governance and commercial flexibility into core strategic capabilities for market participants.
Deep segmentation analysis showing how product type, portability, clinical application, and end-user distinctions create distinct strategic imperatives for manufacturers and providers
Segment-level dynamics reveal differentiated demand drivers and competitive pressures across product types, portability options, clinical applications, and end users. By product type, computed tomography systems span high-slice, mid-slice, and low-slice CT scanners that serve distinct diagnostic profiles, while magnetic resonance imaging equipment is differentiated between closed and open MRI configurations that address trade-offs between image quality and patient accessibility. Nuclear imaging is segmented into PET and SPECT systems, with PET offering molecular-level insights and SPECT providing broader availability for certain diagnostic indications. Ultrasound is diversified across 2D systems, 3D and 4D platforms, and Doppler variants that each target specific use cases from routine screening to procedural guidance. X-ray systems continue to evolve from analog to digital configurations, with digital platforms enabling connectivity and image management integration.
In terms of portability, fixed imaging equipment remains predominant for high-throughput institutional settings, whereas portable imaging equipment-ranging from handheld devices to transportable units-expands access at the bedside and in outpatient settings, addressing the growing need for point-of-care diagnostics. Clinical application segmentation highlights modality-specific traction in cardiology with coronary and vascular imaging, neurology with brain and spinal cord imaging, obstetrics and gynecology focused on fetal monitoring and pelvic imaging, oncology centered on early detection and staging and monitoring, and orthopedics emphasizing fracture detection and joint examination. End users span ambulatory care centers, standalone diagnostic imaging centers, and hospitals and clinics, each with unique procurement cycles, capital constraints, and service expectations. Understanding these layered segmentations is essential for aligning product features, pricing structures, and sales strategies with the clinical and operational realities of each buyer cohort.
Regional variations in healthcare infrastructure, regulation, and procurement priorities across the Americas, Europe Middle East & Africa, and Asia-Pacific that dictate tailored commercial approaches
Regional market dynamics are driven by divergent healthcare infrastructure maturity, regulatory environments, and investment priorities across the Americas, Europe, Middle East & Africa, and Asia-Pacific. In the Americas, advanced hospital systems and a high concentration of diagnostic imaging specialists drive demand for premium modalities and integrated informatics, while private payers and complex reimbursement structures influence purchasing cadences and vendor selection criteria. The region’s focus on precision imaging and interventional guidance continues to foster adoption of advanced CT and MRI platforms.
Europe, the Middle East & Africa present a heterogeneous landscape where Western European markets emphasize standardization, interoperability, and regulatory conformity, and emerging markets within the broader region prioritize access, cost-effectiveness, and scalable solutions. Regulatory harmonization efforts and cross-border procurement initiatives are shaping manufacturer strategies. Asia-Pacific exhibits robust demand elasticity driven by expanding healthcare infrastructure, rising clinical capacity, and government-led initiatives to broaden diagnostic access; this has heightened interest in scalable digital X-ray, portable ultrasound, and mid-range CT solutions. Each regional dynamic requires differentiated commercial approaches that account for capital availability, reimbursement mechanisms, and local service capabilities, and successful market entry or expansion depends on calibrated partnerships and adaptive pricing models.
Competitive landscape dynamics showing how incumbents, niche innovators, and technology entrants are competing through service networks, software integration, and clinical value
Competitive dynamics are shaped by a mix of established multinational manufacturers, specialty-focused original equipment manufacturers, and an emerging cohort of technology entrants that combine imaging hardware with advanced software and analytics. Established players continue to leverage broad installed bases, comprehensive service networks, and integrated modality portfolios to maintain deep customer relationships. At the same time, niche vendors are gaining traction by delivering targeted innovations such as compact form factors, modality-specific AI tools, and cost-optimized service models that address under-served segments.
Strategic imperatives for leading companies include investing in interoperable platforms, expanding digital service offerings, and forming alliances with cloud and analytics providers to deliver lifecycle value beyond the point of sale. Mergers and partnerships are also being used to accelerate capability acquisition, particularly around software-defined imaging and advanced visualization. To sustain differentiation, companies must strengthen field-service capabilities, ensure rapid spare parts availability, and demonstrate clinical value through peer-reviewed studies and real-world evidence. Robust product road maps that integrate enhancements to image quality, throughput, and clinician usability will remain decisive factors in competitive positioning.
Practical strategic initiatives that industry leaders can implement to enhance portfolio adaptability, supply chain resilience, and clinical value delivery in imaging equipment
Leaders seeking to strengthen market position should prioritize several actionable steps that align commercial execution with clinical and operational realities. First, redesign product portfolios to emphasize modularity and upgradeability, enabling customers to extend asset lifecycles while preserving upgrade revenue streams. Second, integrate AI and workflow automation into core offerings to reduce interpretation time, standardize reporting, and enhance prioritization for urgent cases, thereby creating measurable value for radiology departments. Third, enhance supply chain transparency and resilience by diversifying component sourcing, qualifying alternate vendors, and establishing regional service hubs to minimize downtime risks.
Additionally, firms should cultivate collaborative relationships with health systems and diagnostic centers to co-develop pragmatic deployment models such as managed equipment services, pay-per-use arrangements, and outcome-linked contracts. Sales teams must be equipped with total cost of ownership tools and clinical evidence packages that speak directly to procurement committees and value-based care leaders. Finally, invest in training and remote support capabilities to ensure rapid adoption and to reduce barriers associated with new technology uptake. Taken together, these initiatives will enable companies to capture growing demand while mitigating operational and policy-related risks.
Methodological approach detailing how practitioner interviews, regulatory analysis, and cross-validated secondary research were combined to produce robust strategic insights
This research synthesizes primary qualitative interviews with procurement leaders, clinical specialists, and service operations executives alongside comprehensive secondary analysis of regulatory announcements, standards updates, and published clinical literature. The methodology emphasizes triangulation: insights derived from frontline practitioner interviews were cross-referenced with manufacturer disclosures, supplier ecosystem mappings, and regulatory changes to validate thematic findings. Where appropriate, case studies were used to illustrate how specific institutions managed procurement decisions, tariff impacts, and modality selection under varying capital constraints.
Data collection prioritized recency and relevance, with particular attention to policy shifts and supply chain events that have materially altered decision-making behavior. Analytical frameworks included segmentation analysis by product type, portability, clinical application, and end-user to reveal divergent demand patterns and purchasing rationales. Competitive assessment combined capability mapping with service footprint evaluation to identify potential gaps and partnership opportunities. The approach deliberately avoided reliance on single-source assertions and instead focused on corroborated trends and practitioner-validated best practices to inform strategic recommendations.
Concluding perspective emphasizing the need for integrated technological, operational, and commercial strategies to realize the full potential of diagnostic imaging investments
In closing, the diagnostic imaging equipment landscape presents both opportunity and challenge for manufacturers, providers, and service organizations. Technological progress and shifting care models are expanding the scope and utility of imaging across clinical pathways, while policy and supply chain pressures demand heightened commercial agility and operational resilience. Stakeholders who align product strategies with modality-specific clinical needs, strengthen supply chain governance, and build compelling evidence of clinical and economic value will be best positioned to capture long-term opportunities.
Strategic execution requires a disciplined focus on integration-across modalities, across IT systems, and across service models-to deliver measurable improvements in diagnostic speed, accuracy, and patient experience. Organizations that combine technological innovation with pragmatic deployment strategies and transparent commercial terms will unlock the highest value for clinicians and patients alike. The path forward hinges on deliberate investments that balance near-term operational reliability with long-term platform extensibility.
Please Note: PDF & Excel + Online Access - 1 Year
A concise executive overview framing how technological convergence, care delivery shifts, and policy changes are redefining strategic priorities across diagnostic imaging
The diagnostic imaging equipment landscape is undergoing fundamental transformation driven by converging technological advances, regulatory evolution, and shifting care delivery models. As healthcare systems prioritize earlier diagnosis, minimally invasive interventions, and outpatient care expansion, imaging modalities are becoming central to clinical decision pathways and operational efficiency. Diagnostic imaging equipment manufacturers, hospital systems, and service providers must therefore recalibrate product road maps, deployment strategies, and value propositions to remain relevant in increasingly integrated care ecosystems.
This executive-level overview synthesizes key trends shaping the industry, highlights structural shifts in demand and supply, and identifies practical implications for manufacturers, distributors, and clinical stakeholders. It emphasizes the interplay between modality innovation and workflow optimization, and explores how emerging interoperability standards, AI-enabled interpretive tools, and modality convergence are reshaping procurement criteria and capital allocation choices. The goal is to equip decision-makers with a clear, concise narrative of market dynamics and strategic levers that can be acted upon to preserve competitive advantage and drive sustainable growth.
Key structural transformations including modality convergence, AI-enabled workflows, and care delivery migration that are reshaping procurement and deployment strategies
Several transformative shifts are reframing competitive dynamics and clinical utility across the diagnostic imaging ecosystem. Advancements in image acquisition hardware and software are accelerating cross-modality integration, enabling workflows where CT, MRI, ultrasound, nuclear imaging, and X-ray systems complement one another rather than operate in silos. This technical convergence is amplified by the proliferation of AI-enabled analytics that augment image interpretation, automate routine measurements, and prioritize case triage, thus changing expectations for diagnostic throughput and radiologist workflows.
Concurrently, care delivery is migrating toward outpatient, ambulatory, and point-of-care environments, which increases demand for portable and lower-footprint imaging solutions that preserve diagnostic fidelity. Value-based reimbursement models and bundled payments are shifting procurement emphasis toward total cost of ownership, clinical outcomes, and time-to-diagnosis metrics. Supply chain resilience and component sourcing strategies have also become strategic differentiators after recent disruptions, prompting manufacturers to diversify supply bases, localize critical manufacturing, and invest in service networks that reduce uptime risk. Collectively, these shifts are driving a re-evaluation of product design, go-to-market approaches, and partnership strategies across the value chain.
How tariff policy changes enacted in 2025 are reshaping manufacturing footprints, supply chain strategies, and procurement behaviors across the imaging equipment value chain
The cumulative effect of tariff adjustments and trade policy changes implemented in and around 2025 has introduced new layers of complexity into procurement, pricing, and supply chain planning for diagnostic imaging equipment. Tariff-induced cost pressures have compelled manufacturers to reassess component sourcing, production footprints, and pricing strategies for both established and emerging modalities. These adjustments have ripple effects across procurement cycles, capital planning horizons, and long-term service agreements for healthcare providers.
In response, manufacturers are increasingly pursuing near-shoring, diversified supplier ecosystems, and modular design principles that allow critical subassemblies to be sourced from multiple geographies without compromising regulatory compliance or product integrity. Service and spare parts logistics have been reprioritized to mitigate tariff-driven lead-time variability, with an emphasis on extended warranty structures and predictive maintenance contracts that stabilize total lifecycle costs for end users. At the system level, procurement teams are adopting more rigorous scenario planning, incorporating tariff sensitivity analyses into procurement committees, and prioritizing vendors who demonstrate transparent costing and resilient supply chains. Transitional policy shifts have therefore elevated supply chain governance and commercial flexibility into core strategic capabilities for market participants.
Deep segmentation analysis showing how product type, portability, clinical application, and end-user distinctions create distinct strategic imperatives for manufacturers and providers
Segment-level dynamics reveal differentiated demand drivers and competitive pressures across product types, portability options, clinical applications, and end users. By product type, computed tomography systems span high-slice, mid-slice, and low-slice CT scanners that serve distinct diagnostic profiles, while magnetic resonance imaging equipment is differentiated between closed and open MRI configurations that address trade-offs between image quality and patient accessibility. Nuclear imaging is segmented into PET and SPECT systems, with PET offering molecular-level insights and SPECT providing broader availability for certain diagnostic indications. Ultrasound is diversified across 2D systems, 3D and 4D platforms, and Doppler variants that each target specific use cases from routine screening to procedural guidance. X-ray systems continue to evolve from analog to digital configurations, with digital platforms enabling connectivity and image management integration.
In terms of portability, fixed imaging equipment remains predominant for high-throughput institutional settings, whereas portable imaging equipment-ranging from handheld devices to transportable units-expands access at the bedside and in outpatient settings, addressing the growing need for point-of-care diagnostics. Clinical application segmentation highlights modality-specific traction in cardiology with coronary and vascular imaging, neurology with brain and spinal cord imaging, obstetrics and gynecology focused on fetal monitoring and pelvic imaging, oncology centered on early detection and staging and monitoring, and orthopedics emphasizing fracture detection and joint examination. End users span ambulatory care centers, standalone diagnostic imaging centers, and hospitals and clinics, each with unique procurement cycles, capital constraints, and service expectations. Understanding these layered segmentations is essential for aligning product features, pricing structures, and sales strategies with the clinical and operational realities of each buyer cohort.
Regional variations in healthcare infrastructure, regulation, and procurement priorities across the Americas, Europe Middle East & Africa, and Asia-Pacific that dictate tailored commercial approaches
Regional market dynamics are driven by divergent healthcare infrastructure maturity, regulatory environments, and investment priorities across the Americas, Europe, Middle East & Africa, and Asia-Pacific. In the Americas, advanced hospital systems and a high concentration of diagnostic imaging specialists drive demand for premium modalities and integrated informatics, while private payers and complex reimbursement structures influence purchasing cadences and vendor selection criteria. The region’s focus on precision imaging and interventional guidance continues to foster adoption of advanced CT and MRI platforms.
Europe, the Middle East & Africa present a heterogeneous landscape where Western European markets emphasize standardization, interoperability, and regulatory conformity, and emerging markets within the broader region prioritize access, cost-effectiveness, and scalable solutions. Regulatory harmonization efforts and cross-border procurement initiatives are shaping manufacturer strategies. Asia-Pacific exhibits robust demand elasticity driven by expanding healthcare infrastructure, rising clinical capacity, and government-led initiatives to broaden diagnostic access; this has heightened interest in scalable digital X-ray, portable ultrasound, and mid-range CT solutions. Each regional dynamic requires differentiated commercial approaches that account for capital availability, reimbursement mechanisms, and local service capabilities, and successful market entry or expansion depends on calibrated partnerships and adaptive pricing models.
Competitive landscape dynamics showing how incumbents, niche innovators, and technology entrants are competing through service networks, software integration, and clinical value
Competitive dynamics are shaped by a mix of established multinational manufacturers, specialty-focused original equipment manufacturers, and an emerging cohort of technology entrants that combine imaging hardware with advanced software and analytics. Established players continue to leverage broad installed bases, comprehensive service networks, and integrated modality portfolios to maintain deep customer relationships. At the same time, niche vendors are gaining traction by delivering targeted innovations such as compact form factors, modality-specific AI tools, and cost-optimized service models that address under-served segments.
Strategic imperatives for leading companies include investing in interoperable platforms, expanding digital service offerings, and forming alliances with cloud and analytics providers to deliver lifecycle value beyond the point of sale. Mergers and partnerships are also being used to accelerate capability acquisition, particularly around software-defined imaging and advanced visualization. To sustain differentiation, companies must strengthen field-service capabilities, ensure rapid spare parts availability, and demonstrate clinical value through peer-reviewed studies and real-world evidence. Robust product road maps that integrate enhancements to image quality, throughput, and clinician usability will remain decisive factors in competitive positioning.
Practical strategic initiatives that industry leaders can implement to enhance portfolio adaptability, supply chain resilience, and clinical value delivery in imaging equipment
Leaders seeking to strengthen market position should prioritize several actionable steps that align commercial execution with clinical and operational realities. First, redesign product portfolios to emphasize modularity and upgradeability, enabling customers to extend asset lifecycles while preserving upgrade revenue streams. Second, integrate AI and workflow automation into core offerings to reduce interpretation time, standardize reporting, and enhance prioritization for urgent cases, thereby creating measurable value for radiology departments. Third, enhance supply chain transparency and resilience by diversifying component sourcing, qualifying alternate vendors, and establishing regional service hubs to minimize downtime risks.
Additionally, firms should cultivate collaborative relationships with health systems and diagnostic centers to co-develop pragmatic deployment models such as managed equipment services, pay-per-use arrangements, and outcome-linked contracts. Sales teams must be equipped with total cost of ownership tools and clinical evidence packages that speak directly to procurement committees and value-based care leaders. Finally, invest in training and remote support capabilities to ensure rapid adoption and to reduce barriers associated with new technology uptake. Taken together, these initiatives will enable companies to capture growing demand while mitigating operational and policy-related risks.
Methodological approach detailing how practitioner interviews, regulatory analysis, and cross-validated secondary research were combined to produce robust strategic insights
This research synthesizes primary qualitative interviews with procurement leaders, clinical specialists, and service operations executives alongside comprehensive secondary analysis of regulatory announcements, standards updates, and published clinical literature. The methodology emphasizes triangulation: insights derived from frontline practitioner interviews were cross-referenced with manufacturer disclosures, supplier ecosystem mappings, and regulatory changes to validate thematic findings. Where appropriate, case studies were used to illustrate how specific institutions managed procurement decisions, tariff impacts, and modality selection under varying capital constraints.
Data collection prioritized recency and relevance, with particular attention to policy shifts and supply chain events that have materially altered decision-making behavior. Analytical frameworks included segmentation analysis by product type, portability, clinical application, and end-user to reveal divergent demand patterns and purchasing rationales. Competitive assessment combined capability mapping with service footprint evaluation to identify potential gaps and partnership opportunities. The approach deliberately avoided reliance on single-source assertions and instead focused on corroborated trends and practitioner-validated best practices to inform strategic recommendations.
Concluding perspective emphasizing the need for integrated technological, operational, and commercial strategies to realize the full potential of diagnostic imaging investments
In closing, the diagnostic imaging equipment landscape presents both opportunity and challenge for manufacturers, providers, and service organizations. Technological progress and shifting care models are expanding the scope and utility of imaging across clinical pathways, while policy and supply chain pressures demand heightened commercial agility and operational resilience. Stakeholders who align product strategies with modality-specific clinical needs, strengthen supply chain governance, and build compelling evidence of clinical and economic value will be best positioned to capture long-term opportunities.
Strategic execution requires a disciplined focus on integration-across modalities, across IT systems, and across service models-to deliver measurable improvements in diagnostic speed, accuracy, and patient experience. Organizations that combine technological innovation with pragmatic deployment strategies and transparent commercial terms will unlock the highest value for clinicians and patients alike. The path forward hinges on deliberate investments that balance near-term operational reliability with long-term platform extensibility.
Please Note: PDF & Excel + Online Access - 1 Year
Table of Contents
185 Pages
- 1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency
- 1.5. Language
- 1.6. Stakeholders
- 2. Research Methodology
- 3. Executive Summary
- 4. Market Overview
- 5. Market Insights
- 5.1. Integration of AI-driven image analysis software in diagnostic imaging workflows to improve accuracy and efficiency
- 5.2. Rapid adoption of photon-counting CT scanners for enhanced spatial resolution and reduced radiation dose
- 5.3. Development of portable and handheld ultrasound devices enabling point-of-care diagnostics in remote settings
- 5.4. Increasing deployment of hybrid PET/MRI systems for simultaneous metabolic and structural imaging in oncology
- 5.5. Expansion of cloud-based PACS solutions with secure data sharing and AI-powered diagnostic support tools
- 6. Cumulative Impact of United States Tariffs 2025
- 7. Cumulative Impact of Artificial Intelligence 2025
- 8. Diagnostic Imaging Equipment Market, by Product Type
- 8.1. Computed Tomography (CT) Scanners
- 8.1.1. High-Slice CT Scanners
- 8.1.2. Low-Slice CT Scanners
- 8.1.3. Mid-Slice CT Scanners
- 8.2. Magnetic Resonance Imaging (MRI) Equipment
- 8.2.1. Closed MRI Systems
- 8.2.2. Open MRI Systems
- 8.3. Nuclear Imaging Equipment
- 8.3.1. PET Systems
- 8.3.2. SPECT Systems
- 8.4. Ultrasound Systems
- 8.4.1. 2D Ultrasound Systems
- 8.4.2. 3D & 4D Ultrasound Systems
- 8.4.3. Doppler Ultrasound Systems
- 8.5. X-Ray Systems
- 8.5.1. Analog X-Ray Systems
- 8.5.2. Digital X-Ray Systems
- 9. Diagnostic Imaging Equipment Market, by Portability
- 9.1. Fixed Imaging Equipment
- 9.2. Portable Imaging Equipment
- 9.2.1. Handheld Portable Devices
- 9.2.2. Transportable Equipment
- 10. Diagnostic Imaging Equipment Market, by Application
- 10.1. Cardiology
- 10.1.1. Coronary Imaging
- 10.1.2. Vascular Imaging
- 10.2. Neurology
- 10.2.1. Brain Scans
- 10.2.2. Spinal Cord Imaging
- 10.3. Obstetrics & Gynecology
- 10.3.1. Fetal Monitoring
- 10.3.2. Pelvic Imaging
- 10.4. Oncology
- 10.4.1. Early Detection
- 10.4.2. Staging & Monitoring
- 10.5. Orthopedics
- 10.5.1. Fracture Detection
- 10.5.2. Joint Examination
- 11. Diagnostic Imaging Equipment Market, by End-User
- 11.1. Ambulatory Care Centers
- 11.2. Diagnostic Imaging Centers
- 11.3. Hospitals & Clinics
- 12. Diagnostic Imaging Equipment Market, by Region
- 12.1. Americas
- 12.1.1. North America
- 12.1.2. Latin America
- 12.2. Europe, Middle East & Africa
- 12.2.1. Europe
- 12.2.2. Middle East
- 12.2.3. Africa
- 12.3. Asia-Pacific
- 13. Diagnostic Imaging Equipment Market, by Group
- 13.1. ASEAN
- 13.2. GCC
- 13.3. European Union
- 13.4. BRICS
- 13.5. G7
- 13.6. NATO
- 14. Diagnostic Imaging Equipment Market, by Country
- 14.1. United States
- 14.2. Canada
- 14.3. Mexico
- 14.4. Brazil
- 14.5. United Kingdom
- 14.6. Germany
- 14.7. France
- 14.8. Russia
- 14.9. Italy
- 14.10. Spain
- 14.11. China
- 14.12. India
- 14.13. Japan
- 14.14. Australia
- 14.15. South Korea
- 15. Competitive Landscape
- 15.1. Market Share Analysis, 2024
- 15.2. FPNV Positioning Matrix, 2024
- 15.3. Competitive Analysis
- 15.3.1. Agfa-Gevaert Group
- 15.3.2. Analogic Corporation
- 15.3.3. Avonix Imaging, LLC by Nikon Corporation
- 15.3.4. Barco NV
- 15.3.5. Bracco S.p.A.
- 15.3.6. Canon Medical Systems Corporation
- 15.3.7. Carestream Health, Inc.
- 15.3.8. Esaote S.p.A
- 15.3.9. FUJIFILM Holdings Corporation
- 15.3.10. GE HealthCare Technologies Inc.
- 15.3.11. Hologic, Inc.
- 15.3.12. Konica Minolta, Inc.
- 15.3.13. Koninklijke Philips N.V.
- 15.3.14. Medtronic PLC
- 15.3.15. MinFound Medical Systems Co., Ltd.
- 15.3.16. Neusoft Corporation
- 15.3.17. Planmed Oy
- 15.3.18. Samsung Electronics Co., Ltd
- 15.3.19. Shanghai United Imaging Healthcare Co., Ltd.
- 15.3.20. Shenzhen Mindray Bio-Medical Electronics Co Ltd
- 15.3.21. Shenzhen SONTU Medical Imaging Equipment Co., Ltd.
- 15.3.22. Shimadzu Corporation
- 15.3.23. Siemens Healthineers
- 15.3.24. Stryker Corporation
- 15.3.25. Ziehm Imaging GmbH
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
